Journal Home
Search for

Volume 17, Issue 1, Pages 47-54 (January 2010)


View previous. 10 of 14 View next.

Wogonin, an active compound in Scutellaria baicalensis, induces apoptosis and reduces telomerase activity in the HL-60 leukemia cells

Sheng-Teng HuangaCorresponding Author Informationemail address, Chen-Yu Wangb, Rong-Chi Yangc, Chih-Ju Chua, Hsiao-Ting Wua, Jong-Hwei S. PangdCorresponding Author Informationemail address

published online 24 July 2009.

Abstract 

Crude extract of Scutellaria baicalensis (S. baicalensis) has cytotoxic effect on human myelogenous leukemia cells (HL-60). We invesigated which compound from the crude extract is responsible for the cytotoxic effect on HL-60 cells. We identified 29 compounds from the crude extract using high performance liquid chromatography mass spectrometry (HPLC/MS). Two of the compounds, baicalin and wogonoside, are converted to baicalein and wogonin, respectively, after treatment with β-glucuronidase. We observed a dose-dependent reduction in cell viability when cells with either wogonin or aqueous extract of S. baicalensis. Several of the apoptotic features including deoxyribonucleic acid (DNA) fragmentation and increased caspase-3 activity were found in cells treated with wogonin and aqueous extract. The changes were associated with down-regulation of Bcl-2, and not Bax. Furthermore, treatment of HL-60 cells with wogonin or S. baicalensis led to the inhibition of human telomerase reverse transcriptase (hTERT), human telomerase-associated protein 1 (hTP1) and c-myc messenger ribonucleic acid (m-RNA) expression. Wogonin and S. baicaleisis down-regulated the telomerase activity. Our findings suggest that wogonin may be the major compound in S. baicalensis responsible for HL-60 growth inhibition in vitro. The inhibition of HL-60 cell growth is mediated partly through the induction of Bax/Bcl-2 apoptosis and by telomerase inhibition through suppression of c-myc, which is a promoter of hTERT.

a Department of Chinese Medicine, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Taiwan

b School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan

c Chinese Herbal Pharmacy, Chang Gung Memorial Hospital, Tao-Yuan, Taiwan

d Graduate Institute of Clinical Medical Sciences, Chang Gung University, Tao-Yuan, Taiwan

Corresponding Author InformationCorresponding author. Tel.: +88677317123x2334; fax: +88677317123x2335.

Corresponding Author InformationAlso to be corresponded: Tel.: +88632118800x3482; fax: +88633280170.

PII: S0944-7113(09)00161-5

doi:10.1016/j.phymed.2009.06.005


View previous. 10 of 14 View next.